XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Operating expenses:        
Research and development $ 1,713,973 $ 1,480,485 $ 3,305,115 $ 3,360,385
General and administrative 2,394,912 2,014,777 4,747,009 4,590,043
Total operating expenses 4,108,885 3,495,262 8,052,124 7,950,428
Loss from operations (4,108,885) (3,495,262) (8,052,124) (7,950,428)
Other income, net 93,618 250,197 230,180 452,125
Net loss $ (4,015,267) $ (3,245,065) $ (7,821,944) $ (7,498,303)
Net loss available to common stockholders per share of common stock, basic $ (0.47) $ (0.39) $ (0.92) $ (0.89)
Net loss available to common stockholders per share of common stock, diluted $ (0.47) $ (0.39) $ (0.92) $ (0.89)
Weighted average number of shares used in calculating net loss per share, basic 8,543,919 8,401,047 8,493,394 8,401,047
Weighted average number of shares used in calculating net loss per share, diluted 8,543,919 8,401,047 8,493,394 8,401,047
Other comprehensive income (loss):        
Reclassification adjustment for interest earned on marketable securities included in net loss $ (161,197) $ (290,426)
Change in unrealized gain on marketable securities 117,895 328,147
Comprehensive loss $ (4,015,267) $ (3,288,367) $ (7,821,944) $ (7,460,582)